BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Cytovation and SMS-oncology sign agreement on conduct of phase I/II trial with CyPep-1 in solid tumors

  Cytovation AS and Specialized Medical Services-oncology BV announce that SMS-oncology has been selected as the CRO to conduct the phase I/II clinical trial with CyPep-1 in patients with advanced solid cancers.

  August 11, 2019

   · 

  3 min read
• Deals

  HALIX Starts Operational Production with New cGMP Facility in Q4-2019

  HALIX announced that they have met their major milestone with the interim delivery of their new 6,700 m2 cGMP facility in Leiden Bio Science Park.

  August 11, 2019

   · 

  3 min read
• Forbes names ICON in list of Best Employers in America for Women

  ICON recognised as top employer for women in anonymous survey of 60,000 employees

  August 11, 2019

   · 

  3 min read
• Business

  Santhera Announces Executive Management Change

  Santhera Pharmaceuticals announces that Christoph Rentsch has decided to step down as Chief Financial Officer of Santhera by end of this year, in order to pursue his career outside the Company.

  August 11, 2019

   · 

  2 min read
• Drug Development

  Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan’s bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease

  Akari Therapeutics, plc announced new preclinical and human data demonstrating the potential benefits of the dual inhibition of complement (C5) and leukotriene (LTB4) pathways by nomacopan for the treatment of pemphigoid disease (PD).

  August 11, 2019

   · 

  7 min read
• Policy

  Biocardia Announces Issuance Of European Patent For Breakthrough Diagnostic Assay For Patient Selection Prior To Cardiac Cell Therapy Delivery

  BioCardia®, Inc. announced that the European Patent Office has issued the Company Patent No: 3063172 for “Methods of Measuring Potential for Therapeutic Potency and Defining Dosages for Autologous Cell Therapies.”

  August 11, 2019

   · 

  3 min read
• Policy

  Key Family 2 Patent Granted in Europe for RECCE® Antibiotics

  Recce Pharmaceuticals Limited announced the European Patent Office has granted its patent applications for wholly owned RECCE® antibiotics, including lead compound RECCE® 327 furthering marketing/manufacturing monopolies and expanding clinical indications.

  August 11, 2019

   · 

  1 min read
• CMA Foundation announces recipients of this year’s Healthy Canadians Grants

  The CMA Foundation is thrilled to announce the 15 recipients of the 2019 Healthy Canadians Grants program.

  August 11, 2019

   · 

  5 min read
• Biotech Bay

  Paradigm Executives Deliver Insight on their Human-centered, Outcomes-driven Approach at 74th Annual Workers’ Compensation Education Conference

  Paradigm announced its participation at the 74th Annual Workers’ Compensation Education Conference and 30th Annual Safety & Health Conference, on August 10 - 13, 2019 in Orlando, Florida.

  August 11, 2019

   · 

  1 min read
• Media Advisory - CMA Health Summit Day 1: Harnessing technology in Canadian health care system

  Tomorrow the Canadian Medical Association is kicking off its 2nd annual CMA Health Summit to highlight and discuss how to scale up and harness technology to improve connectivity within the health care system.

  August 11, 2019

   · 

  1 min read